factor II

Also found in: Dictionary, Medical, Legal, Financial, Encyclopedia, Wikipedia.
Related to factor II: factor IIa
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for factor II

a protein in blood plasma that is the inactive precursor of thrombin

References in periodicals archive ?
The Gene Proof Factor II prothrombin PCR kit (Brno, Czech Republic) was used for the detection of F2 G20210A mutation in the prothrombin gene using real-time PCR method following the instructions of the manufacturer of the kit.
Pharmaceuticals company Roche (SIX:RO)(OTCQX:RHHBY) stated on Tuesday that it has passed the US FDA clearance for the cobas Factor II and Factor V Test for use on the cobas 4800 system for testing of patients for inherited thrombophilia.
Zhang, "Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer," Journal of Immunology Research, vol.
Factor I is "sleepiness on rising," factor II "initiation and maintenance of sleep," factor III "frequent dreaming," factor IV "refreshing," and factor V "sleep length." Data are presented as mean [+ or -] S.D.
Herein, we report a case presenting with wrist pain mimicking de Quervain's syndrome diagnosed as subacute brachial artery thrombosis due to factor II gene mutation.
Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males.
Scalia et al., "Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells," Molecular and Cellular Biology, vol.
Test Result Reference Interval PT (a) 91.3s 12.5-15.5 s aPTT 128s 25-35 s Fibrinogen 495 mg/dL 175-400 mg/dL Factor II 5% 50%-150% Factor V 98% 50%-150% Factor VII 10% 50%-150% Factor IX 8% 50%-150% (a) PT, prothrombin time; aPTT, activated partial thromboplastin time.
Given the exploratory nature of WCS construct, we opted not to eliminate Factor II even though its Cronbach's Alphas have not reached minimum parameter of 0.7.
Estrogen could lead to increase of synthesis of several coagulation factors including fibrinogen, factor II, VII, and X, and at the same time, thrombin inhibitors such as synthetic and activities of antithrombin III, protein C, and protein S were reduced, which made the blood easier to coagulate, more prone to cause thrombosis.
AutoGenomics expects to initially offer a menu of 11 tests with the INFINITI[R] SMART including pharmacogenomics tests for CYP2D6, 2C19, 2C9-VKORC1, 3A4, 3A5, Apo E, Factor II, Factor V, MTHFR, Flu and HCV genotyping.
Factor I (items 5, 8 and 9) accounted for 30.3% of the variance, Factor II (items 4 and 10) for 28.25% and Factor III (items 3, 6 and 7) for 14.2%.
PT test is used to evaluate the activity of coagulation factors involved in an external way of coagulation (factor II, V, VII, X), assessment of synthetic liver function, control dose of oral anticoagulant therapy with coumarins.